期刊文献+

Wnt-7a蛋白抑制单侧输尿管梗阻小鼠肾脏上皮细胞-间充质细胞转分化 被引量:2

Wnt-7a inhibites epithelial to mesenchymal transition in mice of unilateral ureteral obstruction model
原文传递
导出
摘要 目的 观察Wnt-7a蛋白对单侧输尿管梗阻(UUO)模型小鼠肾脏纤维化的拮抗作用.方法 18只雄性C57BL/6小鼠按随机数字法分为假手术组、UUO模型组和Wnt-7a蛋白治疗组,每组6只.于术后7d处死小鼠,留取梗阻侧肾组织,行Masson染色观察肾间质纤维化程度;免疫组化染色检测肾组织E-钙黏蛋白、α-平滑肌肌动蛋白( α-SMA)、波形蛋白的表达;Western印迹法测定肾皮质中E-钙黏蛋白和 α-SMA的表达.结果 术后第7天,与假手术组相比,模型组体质量显著下降(P<0.05),肾组织间质纤维化相对面积显著增多(P<0.05),肾组织α-SMA及波形蛋白的表达显著增加(P<0.05),E-钙黏蛋白表达显著减少(P<0.05).与模型组相比,Wnt-7a蛋白治疗组体质量无明显改变(P>0.05),肾组织间质纤维化相对面积显著减少(P<0.05),α-SMA及波形蛋白的表达显著减少(P<0.05),E-钙黏蛋白表达显著增高(P<0.05).结论 Wnt-7a蛋白可以抑制肾脏上皮细胞,间充质细胞转分化的发生而减轻肾脏纤维化. Objective To investigate the protective effects of Wnt-7a protein on renal interstitial fibrosis in mice of unilateral ureteral obstruction (UUO)model.Methods Eighteen male C57BL/6 mice were randomly divided into 3 groups:sham-operation group,the UUO model group and Wnt-7a treatment group.The body weight of mice was measured everyday.All the mice were sacrificed at thc seventh day after the operation.The left kidney was taken for histology evaluation and molecular biology assay.Masson's stain was performed as a main indicator of interstitial fibrosis.The expression of vimentin,α-smooth muscle actin,and E-adherin in renal tissue was detected by immunohistochemistry staining and the expression of α-smooth muscle actin and E-cadhe(nn) in renal tissue was detected by Western blotting.Results Compared with sham-operation group,body weight of the (,)odel group was significantly lower (P〈0.05),and the relative area of interstitial fibrosis was significantly larger (P〈0.05).Furthermore,the expression of vimentin and α-SMA was significantly up-regulated (P〈0.05),and the expression of E-cadherin was significantly down-regulated (P〈0.05).Compared with model group,all the above-mentioned abnormalities were restored to some extent and showed significant differences (P〈0.05) in Wnt-7a treatment group.Conclusion Wnt-7a protein can decrease the interstitial fibrosis by inhibiting epithelial to mesenchymal transition in UUO mice.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2012年第9期720-724,共5页 Chinese Journal of Nephrology
基金 国家自然科学基金(30700375)
关键词 输尿管梗阻 纤维化 WNT蛋白质类 上皮细胞-间充质细胞转分化 Ureteral obstruction Fibrosis Wnt proteins Epithelial-myofibroblast transdifferentiation
  • 相关文献

参考文献3

二级参考文献131

  • 1高艳丽,谌贻璞,董鸿瑞,陈文,邹万忠.慢性马兜铃酸肾病动物模型的建立及牛磺酸对其早期保护作用[J].中国中西医结合杂志,2003,23(S1):109-112. 被引量:15
  • 2张彤,梅长林.多囊蛋白1分子在多囊肾发病中的作用机制[J].中华肾脏病杂志,2005,21(5):300-302. 被引量:8
  • 3肖良,张静,赵海丹.多囊蛋白,钙离子信号转导与常染色体显性遗传性多囊肾病[J].医学综述,2006,12(5):259-261. 被引量:1
  • 4Behrens J, Lowrick O, Klein-Hitpass L, Birchmeier W. The Ecadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 1991, 88:11495-11499
  • 5Birchmeier W, Behrens J, Weidner KM, Frixen UH, Schipper J. Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol 1991, 3:832-840
  • 6Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A, Schalken JA. Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 1997, 241:453-458
  • 7Hajra KM, Ji X, Fearon ER. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 1999, 18:7274-7279
  • 8Ji X, Woodard AS, Rimm DL, Fearon ER. Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ 1997, 8:773-778
  • 9Karreth F, Tuveson DA. Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis. Cancer Biol Ther 2004, 3: 1058-1059
  • 10Thiery JE Morgan M. Breast cancer progression with a Twist. Nat Med 2004, 10:777-778

共引文献76

同被引文献19

  • 1程虹,谌贻璞.肥胖相关性肾小球病研究进展[J].中国实用内科杂志,2007,27(1):62-64. 被引量:4
  • 2谌贻璞,程虹.肥胖相关性肾小球病//谌贻璞,主编.肾内科学.北京:人民卫生出版社,2008:87-97.
  • 3朱运锋,谌贻璞,芮宏亮,董鸿瑞,胡昭.虫草菌粉对慢性马兜铃酸肾病大鼠模型肾间质纤维化的保护作用[J].中华医学杂志,2007,87(38):2667-2671. 被引量:29
  • 4Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity[J]. Ann Intern Med, 1974, 81: 440-447.
  • 5Nagase M. Activation of the receptor system in chronic kidney disease and metabolic syndrome[J]. Clin Exp Nephrol, 2010, 14: 303-314.
  • 6Mark S, John R, Thomas F, et al. Oxygen free radicals in ischemic acute renal failure in the rat[J]. J Clin Invest, 1984, 74: 1156-1164.
  • 7Byung IS, Yi SS, Cheng HF, et al. G-CSF prevents progression of diabetic nephropathy in rat[J]. PLOS ONE, 2013, 8: e77048.
  • 8Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic[J]. Kidney lnt, 2001, 59: 1498-1509.
  • 9Bochud M, Nusaberger J, Borer P, et al. Plasma aldosterene is independently associated with the metabolic syndrome[J]. Hypertension, 2006, 48: 239-245.
  • 10Chrysostomou A, Beeker G. Spironolaetone in addition to ACE inhibition to reduce pmteinuria in patients with chronic renal disease[J]. N Engl J Med, 2001, 345: 925-926.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部